It will be in a thermostable, solid dose implant format for transcutaneous delivery via a needle-free device to prevent infection of pregnant women and the resultant congenital effects in the unborn child.
Enesi Pharma ("Enesi"), the innovative pharmaceutical company developing unique injectable solid dose drug-device vaccine products, is delighted to announce that it has secured substantial funding from Innovate UK, the UK's innovation agency, under the Bi